Search clinical trials for: fondaparinux

Total 83 results

Queen Mary University of London

Not yet recruiting

Thromboprophylaxis in Lower Limb Immobilisation (TiLLI)

Thrombosis | Injury Leg
University of Veterinary and Animal Sciences, Lahore...

Not yet recruiting

Evaluation of Licorice Root on Metabolic Syndrome in Polycystic Ovary Syndrome Females

Polycystic Ovary Syndrome | Metabolic Syndrome
Nantes University Hospital

Recruiting

Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels (UniXa)

Atrial Fibrillation | Venous Thromboembolism | Anticoagulation

France
GUALTIERO PALARETI
Arianna Anticoagulazione Foundation

Recruiting

START-Register: Survey on Anticoagulated Patients Register

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Italy
National Medical Research Center for Therapy and...

Completed

Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein

Endovenous Laser Ablation | Superficial Vein Thrombosis

Russian Federation
Alliance Foundation Trials, LLC.
Patient-Centered Outcomes Research Institute

Completed

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS)

Cancer | Venous Thromboembolism | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Blood Clot

United States
Merck KGaA, Darmstadt, Germany

Completed

Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran Etexilate

Healthy

Germany
GWT-TUD GmbH
Bayer

Completed

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Superficial Vein Thrombosis

Germany
Zeria Pharmaceutical

Completed

A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia

Hyperkalemia

Japan
Daiichi Sankyo, Inc.

Completed

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Pulmonary Embolism | Venous Thromboembolism (VTE) | Deep Vein Thrombosis (DVT)

United States, Israel, Spain, Czechia, Singapore, Canada, Argentina, Brazil, Bulgaria, Chile, Croatia, Denmark, El Salvador, France, Germany, Guatemala, Hungary, India, Kenya, Korea, Republic of, Lebanon, Malaysia, Netherlands, Norway, ... and more
Prairie Education and Research Cooperative
American College of Phlebology

Terminated

A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

Deep Vein Thrombosis | Venous Thromboembolism | Coronary Artery Bypass Surgery
Eastern Virginia Medical School
GlaxoSmithKline

Terminated

Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients

Venous Thromboembolism
Lehigh Valley Hospital
GlaxoSmithKline

Terminated

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients (BRiEF)

Venous Thrombosis

United States
G. d'Annunzio University

Terminated

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia (FAITH)

Thrombocytopenia | Medical Patient

Italy
Medical University of Gdansk
Baxter Healthcare Corporation

Unknown

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis

Poland
Quovadis Associazione
Azienda Ospedaliera di Padova

Completed

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19 (VTE-COVID)

COVID-19 Disease | Thromboembolism, Venous

Italy
Hellenic Society of Surgical Oncology

Unknown

Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism

Cancer | Thromboembolism | Cancer Diagnosis

Greece
National University of Malaysia

Completed

Safety of Fondaparinux as Post Partum Thromboprophylaxis

Thromboembolism in the Puerperium

Malaysia
University of Milan
Fondazione "Un Cuore per Milano" - a no profit foundation

Completed

Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 (PIC-19)

Pneumonia, Viral | Embolism and Thrombosis | Respiratory Failure | Corona Virus Infection

Italy
Children's Hospital of Philadelphia

Withdrawn

Gastrointestinal Implications of Voriconazole Exposure (GIVE)

Infection

United States
University of Louisville
James Graham Brown Cancer Center

Terminated

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Heparin-Induced Thrombocytopenia

United States
Methodist Healthcare
University of Tennessee

Withdrawn

Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)

Heparin-Induced Thrombocytopenia
G. d'Annunzio University

Completed

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Unsuspected Pulmonary Embolism

Spain, France, Netherlands, Italy, United States, Austria, Canada, Germany
Johns Hopkins University
GlaxoSmithKline

Completed

Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

Pulmonary Embolism | Deep Venous Thrombosis

United States
Shirley M. Tsunoda

Unknown

Drug Interaction With Envarsus XR and Grapefruit Juice

Kidney Transplant; Complications | Drug Interaction Food
Daiichi Sankyo Co., Ltd.

Completed

Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs

Venous Thromboembolism

Japan
GlaxoSmithKline

Completed

Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)

Thrombosis, Venous
GlaxoSmithKline

Completed

Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

Thromboembolism
Masonic Cancer Center, University of Minnesota

Completed

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

Sarcoma | Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Thromboembolism | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer

United States
GlaxoSmithKline

Completed

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

Acute HIT II (Heparin-induced Thrombocytopenia Type II)
GlaxoSmithKline

Completed

Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection

Thromboembolism
GlaxoSmithKline

Completed

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

Thrombosis, Venous
Paul Di Cesare,MD

Completed

The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty

Total Knee Replacement

United States
Melbourne Health

Terminated

Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.

Renal Failure

Australia
University of Alabama at Birmingham
GlaxoSmithKline

Terminated

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

Venous Thrombosis

United States
GlaxoSmithKline

Completed

Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) (FUTURA/OASIS 8)

Acute Coronary Syndrome

Canada, France, Bulgaria, Germany, Poland, United Kingdom, Spain, Russian Federation, Korea, Republic of, Netherlands, India, United States, Brazil, Hungary, Italy, Argentina, Czech Republic, Greece
GlaxoSmithKline

Completed

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Thrombosis, Venous

Netherlands, Spain, Germany, Italy, Poland, Russian Federation, France, Israel, Estonia, Hungary, Slovakia, Latvia, Greece, Ukraine, Czech Republic, Switzerland, Bulgaria
The Cleveland Clinic
GlaxoSmithKline

Withdrawn

Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux

Pulmonary Embolism

United States
Bayer
Janssen Research & Development, LLC

Completed

Xarelto Regulatory Post-Marketing Surveillance

Venous Thromboembolism

Korea, Republic of
GlaxoSmithKline

Completed

The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

Embolism, Pulmonary

Japan
GlaxoSmithKline

Completed

The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

Thrombosis, Venous

Japan
GlaxoSmithKline
Sanofi

Completed

OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction

Thromboembolism
GlaxoSmithKline
Sanofi; University of Chicago; Duke University; Organon

Completed

Michelangelo - Oasis 5

Thromboembolism
GlaxoSmithKline
Sanofi

Completed

A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).

Thromboembolism
Northwell Health
GlaxoSmithKline

Terminated

Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism

Cancer | Thromboembolism

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery (FONDACAST)

Thrombosis, Venous

Spain, Germany, Russian Federation, France, Italy, Netherlands
Indiana University School of Medicine
American Society for Bariatric Surgery

Withdrawn

Study to Determine Effective Dosing of Fondaparinux in Obese Persons

Morbid Obesity

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)

Ataxia
GlaxoSmithKline

Completed

Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment

Ataxia
Wayne State University
GlaxoSmithKline

Completed

Fondaparinux in Critically Ill Patients With Renal Failure

Venous Thromboembolism

United States

Search clinical trials for: fondaparinux

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations